Vascular Dementia: The "Other" Dementia and the Blood Sugar Driver Nobody Treats

Heads up before you read: Not medical advice. If you're on blood pressure or anti-coagulation medication, do not change anything without your prescriber. This is about what a real root-cause workup looks like alongside standard care.

Vascular dementia is the "other" dementia your doctor barely mentioned

Alzheimer's gets the headlines. Vascular dementia gets the shrug. But somewhere between 15% and 30% of all dementia is primarily vascular — and the overlap with Alzheimer's is so common that the honest diagnosis for most older adults is "mixed dementia."

The standard-of-care story: "It's small strokes. Control blood pressure, take a statin, baby aspirin, see you in six months." That story misses the actual driver. Vascular dementia isn't a stroke disease. It's a blood sugar + endothelial inflammation + small-vessel disease disease. And every single one of those has a root cause that started decades earlier.

What's actually happening in the small vessels

The cerebral microvasculature — the tiny arterioles, capillaries, and venules that feed the white matter — is one of the most metabolically demanding territories in the body. When it gets damaged, you don't get a dramatic event. You get white-matter hyperintensities on MRI (those "non-specific" white spots radiologists write off), progressive executive dysfunction, slowed processing speed, mood flattening, and gait changes.

The four root drivers we see, in order of prevalence:

1. Chronic glucose dysregulation. Endothelial cells run on glucose, and they fail in hyperglycemia. The classic Whitehall II data showed cognitive decline accelerated when HbA1c crept above 6.0% — years before a diabetes diagnosis. "Pre-diabetes" is a brain disease that politely waits for your pancreas to be the symptom.
2. Endothelial inflammation. hs-CRP, oxidized LDL, homocysteine, lp(a), ADMA. None of these are on the standard lipid panel. All of them predict small-vessel disease better than total cholesterol.
3. Untreated sleep apnea. Intermittent nocturnal hypoxia is brutal on the endothelium. Most women with vascular dementia were undiagnosed apneics for decades.
4. Chronic environmental load. Mold biotoxins, heavy metals, glyphosate, microplastics — all documented endothelial irritants. The brain's microvasculature is the canary.

The standard-of-care misses what matters

Your PCP measures: total cholesterol, LDL, HDL, fasting glucose, blood pressure. That's 1990s medicine.

What actually predicts vascular dementia in 2026:

• HbA1c + fasting insulin + HOMA-IR + post-meal glucose (CGM for 14 days)
• hs-CRP, homocysteine, oxidized LDL, ApoB, Lp(a)
• Carotid IMT or coronary calcium score — structural, not just biochemical
• Overnight pulse oximetry or formal sleep study
• Brain MRI with FLAIR sequences — read by someone who actually counts and grades white-matter hyperintensities, not someone who writes "non-specific changes for age"
• Cognitive baseline — CNS Vital Signs, repeated annually

If you're 45+ and you've never had this workup, you don't have a vascular workup. You have a checkbox.

The 90-day vascular brain protocol

Once you have data, the interventions that move the needle are unsexy and effective:

1. CGM for 14 days, then re-engineer your eating window. Stable glucose is the highest-leverage vascular intervention available. We routinely see HbA1c drop 0.5-1.0 points in 90 days with no medication change.
2. Treat the apnea. If your AHI is over 5, get a CPAP or a mandibular advancement device. The brain doesn't care which one — it cares that you stop desaturating at 3am.
3. Endothelial repair stack. Citrulline, nattokinase, lumbrokinase, omega-3 (EPA-dominant, 2-4g), vitamin K2-MK7, magnesium glycinate — all with your clinician, none replacing existing meds.
4. Move 5 days a week. Zone 2 cardio for vessel compliance, VO2 max work for cerebral blood flow. The Norwegian HUNT3 cohort showed a measurable dementia-risk dose response.
5. Drop the visceral fat. Inflammatory cytokines from visceral adipose tissue hammer the endothelium. A waist circumference > half your height (in cm) is a brain risk factor.

This is root-cause-to-self-implementation, vascular brain edition. We map the drivers; you implement. None of this requires you to fire your cardiologist.

Where to start

→ Take the Health Decode ($47) — find which vascular driver is loudest for you. → Start Foundation — full vascular + metabolic + cognitive workup. → Get the free Brain Brief — the 5 patterns we see in every vascular dementia case.

Listen to the deep-dives

• Dementia starts decades before symptoms — the pre-clinical window where this is reversible.
• How Does Blood Sugar Affect The Brain? — the metabolic driver, in detail.
• The Most Common Neurotoxins Related to Dementia and Alzheimer's — the environmental layer.

FAQ

How do I know if I have vascular dementia versus Alzheimer's? You probably have some of both — "mixed dementia" is the most common pathology in autopsy series of older adults. The treatment overlap is significant; the root causes overlap even more.

Is vascular dementia reversible? Frank vascular dementia, in someone with extensive white-matter disease, is not "reversible" — but the trajectory absolutely is modifiable. Catching pre-clinical small-vessel disease in the 40s and 50s is where prevention lives.

Aren't statins enough? Statins lower LDL. They don't address insulin resistance, endothelial inflammation, sleep apnea, or environmental load. They are one tool. They are not a strategy.

What about the cholesterol-causes-dementia debate? Total cholesterol is a weak predictor. ApoB, Lp(a), oxidized LDL, and hs-CRP are much stronger. Modern lipidology has moved past the 1990s narrative; most PCPs haven't.

Will the Foundation workup show small-vessel disease? Foundation maps the upstream drivers (metabolic, inflammatory, environmental, sleep). Structural imaging (MRI, carotid IMT, CAC) is ordered alongside through your clinician — we provide the requisition framework and interpretation context.